EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 5 (Mai 2004) Med Sci (Paris), 20 5 (2004) 562-568 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 5, Mai 2004
Page(s) 562 - 568
Section SYNTHÈSE
DOI https://doi.org/10.1051/medsci/2004205562
Published online 15 May 2004
  1. http://www-dep.iarc.fr, 2000. [Google Scholar]
  2. Labrie F, Candas B, Dupont A, et al. Screening decreases prostate cancer death : First analysis of the 1988 Quebec prospective randomized controlled trial. Prostate 1999; 38 : 83–91. [Google Scholar]
  3. Cussenot O, Valeri A. Heterogeneity in genetic susceptibility to prostate cancer. Eur J Intern Med 2001; 12 : 11–6. [Google Scholar]
  4. Cussenot O, Fournier G. Génétique et urologie. Paris : les Éditions Vingt et un. Progrès en Urologie 2000 : 417p. [Google Scholar]
  5. Morganti G, Gianferrari L, Cresseri A, et al. Recherches clinico-statistiques et génétiques sur les néoplasies de la prostate. Acta Genet Stat Med 1956; 6 : 304–5. [Google Scholar]
  6. Grönberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in twin population. J Urol 1994; 152 : 1484–9. [Google Scholar]
  7. Schaid DJ, McDonnell SK, Blute ML, et al. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998; 62 : 1425–38. [Google Scholar]
  8. Carter BS, Beaty TH, Steinberg GD, et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89 : 3367–71. [Google Scholar]
  9. Xu J and the International consortium for prostate cancer genetics. Combined analysis of hereditary prostate cancer linkage to 1q24-25 : results from 772 hereditary prostate cancer families from the International consortium for prostate cancer genetics. Am J Hum Genet 2000; 66 : 945–57. [Google Scholar]
  10. Berthon P, Valeri A, Cohen-Akenine A, et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998; 62 : 1416–24. [Google Scholar]
  11. Cancel-Tassin G, Latil A, Valeri A, et al. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Eur J Hum Genet 2001; 9 : 135–42. [Google Scholar]
  12. Karayi MK, Neal DE, Markham AF. Current status of linkage studies in hereditary prostate cancer. BJU Int 2000; 86 : 659–69. [Google Scholar]
  13. Valeri A, Azzouzi R, Drelon E, et al. Early-onset hereditary prostate cancer is not associated with specific clinical biological features. Prostate 2000; 45 : 66–71. [Google Scholar]
  14. Goode EL, Stanford JL, Peters MA, et al. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci. Clin Cancer Res 2001; 7 : 2739–49. [Google Scholar]
  15. Bratt O. Hereditary prostate cancer : Clinical aspects. J Urol 2002; 168 : 906–13. [Google Scholar]
  16. Valeri A, Fournier G, Morin V, et al. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 2000; 86 : 883–7. [Google Scholar]
  17. Edwards SM, Kote-Jarai Z, Meitz J, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003; 72 : 1–12. [Google Scholar]
  18. Gayther SA, de Foy KA, Harrington P, et al. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The cancer research campaign/British prostate group united kingdom familial prostate cancer study collaborators. Cancer Res 2000; 60 : 4513–8. [Google Scholar]
  19. Jonsson BA, Bergh A, Stattin P, et al. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer 2002; 98 : 838–43. [Google Scholar]
  20. Ross RK, Pike MC, Coetzee GA, et al. Androgen metabolism and prostate cancer : Establishing a model of genetic susceptibility. Cancer Res 1998; 58 : 4497–504. [Google Scholar]
  21. Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000; 27 : 39–66. [Google Scholar]
  22. Irvine RA, Yu MC, Ross RK, et al. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995; 55 : 1937–40. [Google Scholar]
  23. Edwards A, Hammond HA, Jin L, et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992; 12 : 241–53. [Google Scholar]
  24. Rebbeck TR, Jaffe JM, Walker AH, et al. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 1998; 90 : 1225–9. [Google Scholar]
  25. Lunn RM, Bell DA, Mohler JL, et al. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis 1999; 20 : 1727–31. [Google Scholar]
  26. Chang BL, Zheng SL, Hawkins GA, et al. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Res 2002; 62 : 1784–9 [Google Scholar]
  27. Latil A, Azzouzi R, Cancel G, et al. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer 2001; 92 : 1130–7. [Google Scholar]
  28. Cancel-Tassin G, Latil A, Rousseau F, et al. Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. Eur Urol 2003; 44 : 487–90. [Google Scholar]
  29. Tang YM, Green BL, Chen GF, et al. Human CYP1B1 Leu432Val gene polymorphism : ethnic distribution in African-Americans, Caucasians and Chinese ; oestradiol hydroxylase activity ; and distribution in prostate cancer cases and controls. Pharmacogenetics 2000; 10 : 761–6. [Google Scholar]
  30. Correa-Cerro L, Berthon P, Haussler J, et al. Vitamin D receptor polymorphisms as markers in prostate cancer. Human Genet 1999; 105 : 281–7. [Google Scholar]
  31. Reszka E, Wasowicz W. Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Neoplasma 2002; 49 : 209–16. [Google Scholar]
  32. Simard J, Dumont M, Soucy P, et al. Perspective : prostate cancer susceptibility genes. Endocrinology 2002; 143 : 2029–40. [Google Scholar]
  33. Nwosu V, Carpten J, Trent JM, et al. Heterogeneity of genetic alterations in prostate cancer : Evidence of the complex nature of the disease. Hum Mol Genet 2001; 10 : 2313–8. [Google Scholar]
  34. Valeri A, Cormier L, Moineau MP, et al. Targeted screening for prostate cancer in high risk families : Early onset is a significant risk factor for disease in first degree relatives. J Urol 2002; 168 : 483–7. [Google Scholar]
  35. Novelli G, Margiotti K, Sangiuolo F, et al. Pharmacogenetics of human androgens and prostatic diseases. Pharmacogenomics 2001; 2 : 65–72. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.